CTOs on the Move

MolecularMD

www.molecularmd.com

 
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Memphis Center for Independent Living

Memphis Center for Independent Living is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OccHealth Systems

OccHealth Systems is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Best Doctors

Best Doctors is the trusted expert medical resource that helps people take control of their healthcare. By connecting members and their treating physicians with world- renowned experts to confirm the right diagnosis and the right treatment, Best Doctors has a dramatic impact on the quality and cost of healthcare. The company delivers comprehensive, patient-centric, expert advice, empowering members and their physicians with specific, pertinent, actionable information. Better than a traditional second opinion, Best Doctors delivers a comprehensive evaluation of a member’s medical condition — providing value to both its members and their treating physicians.

DMS Health Group

DMS Health Group is a Fargo, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neuwave

NeuWave Medical specializes in developing and commercializing energy-based minimally invasive medical devices. These devices must deliver improved healthcare economics and a better experience for patients in terms of outcomes or quality of life. NeuWave Medical, Inc. is a spin-off company from the University of Wisconsin - Madison. NeuWave arose as the result of an academic collaboration between engineers and physicians who wished to improve their ability to treat cancer and other important clinical problems. As a result, NeuWave is highly focused on solving real clinical problems in a manner that will directly benefit patients by being more effective, minimally invasive, and cost conscious.